抗载脂蛋白B抗体(Anti-APOB)检测试剂盒(酶联免疫吸附试验法)

ELISA Kit for Anti-Apolipoprotein B Antibody (Anti-APOB)

Apo-B; FLDB; Apo B-100

  • 抗载脂蛋白B抗体(Anti-APOB)检测试剂盒(酶联免疫吸附试验法)产品包装(模拟)
  • 抗载脂蛋白B抗体(Anti-APOB)检测试剂盒(酶联免疫吸附试验法)产品包装(模拟)
  • 抗载脂蛋白B抗体(Anti-APOB)检测试剂盒(酶联免疫吸附试验法)实验结果图
  • AEC003Hu.jpg标准曲线图
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

本试剂盒用于检测抗载脂蛋白B抗体(Anti-APOB),经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。

回收率

分别于定值血清及血浆样本中加入一定量的抗载脂蛋白B抗体(Anti-APOB)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。

样本回收率范围(%)平均回收率(%)
serum(n=5)98-105101
EDTA plasma(n=5)90-9894
heparin plasma(n=5)98-105101

精密度

精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
批内差: CV<10%
批间差: CV<12%

线性

在定值血清及血浆样本内加入适量的抗载脂蛋白B抗体(Anti-APOB),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中抗载脂蛋白B抗体(Anti-APOB)含量的测定值与理论值的比率。

样本1:21:41:81:16
serum(n=5)95-102%79-88%80-104%82-101%
EDTA plasma(n=5)81-101%83-90%82-103%81-94%
heparin plasma(n=5)90-97%92-101%87-101%83-97%

稳定性

经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。

实验流程

1. 实验前标准品、试剂及样本的准备;
2. 加样(标准品及样本)100µL,37°C孵育1小时;
3. 吸弃,加检测溶液A100μL,37°C孵育1小时;
4. 洗板5次;
5. 加TMB底物90µL,37°C孵育10-20分钟;
6. 加终止液50µL,立即450nm读数。

实验原理

将抗原包被于96孔微孔板中,制成固相载体,向微孔中分别加入标准品或标本,其中的抗载脂蛋白B抗体(Anti-APOB)与连接于固相载体上的抗原结合,然后加入HRP标记的二抗,彻底洗涤后加入TMB底物显色。TMB在过氧化物酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的抗载脂蛋白B抗体(Anti-APOB)呈正相关。用酶标仪在450nm波长下测定吸光度(O.D.值),计算样品浓度。

相关产品

编号适用物种:Homo sapiens (Human,人)应用(仅供研究使用,不用于临床诊断!)
NPC003Hu01载脂蛋白B(APOB)天然蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPC003Hu02载脂蛋白B(APOB)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPC003Hu01载脂蛋白B(APOB)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAC003Hu02载脂蛋白B(APOB)多克隆抗体WB; IHC; ICC; IP.
PAC003Hu01载脂蛋白B(APOB)多克隆抗体WB
LAC003Hu81载脂蛋白B(APOB)多克隆抗体(异硫氰酸荧光素标记)WB; IHC; ICC; IF.
LAC003Hu71载脂蛋白B(APOB)多克隆抗体(生物素标记)WB; IHC; ICC.
MAC003Hu24载脂蛋白B(APOB)单克隆抗体WB; IHC; ICC; IP.
MAC003Hu25载脂蛋白B(APOB)单克隆抗体WB; IHC; ICC; IP.
MAC003Hu23载脂蛋白B(APOB)单克隆抗体WB; IHC; ICC; IP.
MAC003Hu22载脂蛋白B(APOB)单克隆抗体WB; ICC/IF;FCM
MAC003Hu21载脂蛋白B(APOB)单克隆抗体WB
MAC003Hu26载脂蛋白B(APOB)单克隆抗体WB; IHC; ICC; IP.
FAC003Hu06抗载脂蛋白B(APOB)单克隆抗体Flow cytometry.
FAC003Hu04抗载脂蛋白B(APOB)单克隆抗体Flow cytometry.
FAC003Hu02抗载脂蛋白B(APOB)单克隆抗体Flow cytometry.
FAC003Hu08抗载脂蛋白B(APOB)单克隆抗体Flow cytometry.
SEC003Hu载脂蛋白B(APOB)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
HEC003Hu载脂蛋白B(APOB)检测试剂盒(酶联免疫吸附试验法,高敏型)Enzyme-linked immunosorbent assay for Antigen Detection.
AEC003Hu抗载脂蛋白B抗体(Anti-APOB)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antibody Detection.
SCC003Hu载脂蛋白B(APOB)检测试剂盒(化学发光免疫分析法)Chemiluminescent immunoassay for Antigen Detection.
LMC003Hu载脂蛋白B(APOB)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.

参考文献

杂志参考文献
Journal of Lipid ResearchGroup 1B phospholipase A2 deficiency protects against diet-induced hyperlipidemia in mice[Jlr: M019463]
J Clin Endocrinol Metab.?Elevated retinol binding protein 4 induces apolipoprotein B production and associates with hypertriglyceridemia[Pubmed:25781360]
Biochim Biophys ActaCulturing of HepG2 cells with human serum improve their functionality and suitability in studies of lipid metabolism[PubMed: 26515253]
Am J Cardiovasc DisHypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein (a) in transgenic mice[PubMed: 26064792]
The Journal of Biological ChemistryProprotein convertase subtilisin/Kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of LDL receptor degradation[Pubmed:27284008]
United States Patent ApplicationCOMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF SIRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES[y2016:0152988.html]
alcohol and alcoholismHops (Humulus lupulus) Content in Beer Modulates Effects of Beer on the Liver After Acute Ingestion in Female Mice.[pubmed:27659607]
Frontiers in PhysiologyChange in the Lipid Transport Capacity of the Liver and Blood during Reproduction in Rats[pubmed:28798692]
Food Research InternationalWild Lonicera caerulea berry polyphenol extract reduces cholesterol accumulation and enhances antioxidant capacity in vitro and in vivo[Pubmed:29580541]
Journal of The Science of Food and AgricultureConsumption of orange fermented beverage improves antioxidant status and reduces peroxidation lipid and inflammatory markers in healthy humans[Pubmed:29124773]
European Journal of PharmacologyThe effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in?…[Pubmed: 30768981]
Nature CommunicationsHepatic HuR modulates lipid homeostasis in response to high-fat diet[Pubmed: 32546794]
Study of in Vivo Serum Lipid Regulation with Ulmus macrocarpa Hance Extract in Rats[]
Nat CommunGP73 is a TBC-domain Rab GTPase-activating protein contributing to the pathogenesis of non-alcoholic fatty liver disease without obesity[34853313]